Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2010

View Archived Issues

Synthesis and effects of EC-23 on human stem cells described

PF-3450074 inhibits HIV infection by destabilizing viral capsid

MK-0752 shows promise in patients with breast cancer

New antagonists of proteinase-activated PAR1 receptor identified

Abbott patents new activators of voltage-gated K(V)7 potassium channels

New inhibitors of focal adhesion kinase 1 claimed

Novartis divulges new neprilysin inhibitors

New activators of glycoprotein hormone FSH receptor discovered

Scientists unveil mechanism leading to resistance of HIV to maraviroc

[18F]-Marimastat-aryltrifluoroborate described as useful for PET imaging of breast cancer

Phase II study evaluates RGN-259 in dry eye syndrome

Centocor Ortho Biotech files sBLA for Remicade for pediatric ulcerative colitis

Antares files NDA for Anturol gel in overactive bladder

CEQ-508 receives FDA orphan drug status in familial adenomatous polyposis

Forest acquires Gruenenthal's cystic fibrosis franchise in Europe

Cel-Sci begins phase III trial of Multikine in head and neck cancer

Ziopharm Oncology treats first patient in phase I trial of palifosfamide

Recordati and Merck KGaA enter licensing agreement for Cardicor in Italy

Phase I/II trial of belinostat/Tarceva combination in NSCLC advances

Florida Hospital, Sanford-Burnham and Takeda partner to target obesity

Bristol-Myers Squibb and Otsuka to copromote Sprycel in Japan

Phase I/II data reported on OMS-201 in patients undergoing ureteroscopy

Advanced Cell Technology seeks European orphan drug status for MA-09-HRPE

New partial agonists of PPAR-gamma disclosed

Merrion and Novo Nordisk sign agreement for GIPET drug delivery technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...